Top Markets
Coin of the day
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Rang în acțiuni #15401
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Preț acțiune
$9.50
Capitalizare de piață
$357.67M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
92.70%
Țară
US
Tranzacționează BioAge Labs Inc. (BIOA)

Categorie

Istoric al prețului acțiunii pentru BioAge Labs Inc. (BIOA)
Cel mai mare preț de închidere: $9.50 pe 2026-09-01

Cel mai mic preț de închidere: $20.04 pe 2024-09-01
Istoric al prețului acțiunii pentru BioAge Labs Inc. din 2024 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 19.87%
2025 48.86%
2024 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$548.98 40.40%
US
$1.03K 44.32%
NL
$121.37 -11.93%
AU
$144.39 499.38%
US
$748.60 4.92%
CH